The 36-month beta value for SKIN is also noteworthy at 0.96. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 7 rating it as “hold,” and 3 rating it as “sell.”
The public float for SKIN is 77.19M, and at present, short sellers hold a 10.93% of that float. The average trading volume of SKIN on September 06, 2024 was 1.84M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
SKIN) stock’s latest price update
Beauty Health Company (NASDAQ: SKIN)’s stock price has plunge by -8.28relation to previous closing price of 1.69. Nevertheless, the company has seen a -14.84% plunge in its stock price over the last five trading sessions. seekingalpha.com reported 2024-08-10 that At Moats and Monopolies, we focus on long only, high quality businesses but sometimes we like a little asymmetric risk/reward opportunity. The Beauty Health Company has been incredibly volatile over the past couple of years as investors have grown weary that the company may never be profitable. The company still isn’t profitable, causing a sell off after earnings after a $17 million write off for replacing flagship models with technical issues combined with declining revenues.
SKIN’s Market Performance
SKIN’s stock has fallen by -14.84% in the past week, with a monthly rise of 24.00% and a quarterly drop of -25.48%. The volatility ratio for the week is 16.78% while the volatility levels for the last 30 days are 15.21% for Beauty Health Company The simple moving average for the last 20 days is -0.58% for SKIN stock, with a simple moving average of -42.44% for the last 200 days.
Analysts’ Opinion of SKIN
Many brokerage firms have already submitted their reports for SKIN stocks, with Jefferies repeating the rating for SKIN by listing it as a “Hold.” The predicted price for SKIN in the upcoming period, according to Jefferies is $1.50 based on the research report published on November 15, 2023 of the previous year 2023.
SKIN Trading at -9.79% from the 50-Day Moving Average
After a stumble in the market that brought SKIN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.56% of loss for the given period.
Volatility was left at 15.21%, however, over the last 30 days, the volatility rate increased by 16.78%, as shares surge +20.93% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -14.75% lower at present.
During the last 5 trading sessions, SKIN fell by -14.29%, which changed the moving average for the period of 200-days by -30.97% in comparison to the 20-day moving average, which settled at $1.5725. In addition, Beauty Health Company saw -50.16% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SKIN starting from SAUNDERS BRENT L, who purchase 40,450 shares at the price of $1.08 back on Aug 12 ’24. After this action, SAUNDERS BRENT L now owns 5,921,769 shares of Beauty Health Company, valued at $43,686 using the latest closing price.
Stock Fundamentals for SKIN
Current profitability levels for the company are sitting at:
- -0.38 for the present operating margin
- 0.33 for the gross margin
The net margin for Beauty Health Company stands at -0.23. The total capital return value is set at -0.22. Equity return is now at value -72.45, with -9.74 for asset returns.
Based on Beauty Health Company (SKIN), the company’s capital structure generated 0.89 points at debt to capital in total, while cash flow to debt ratio is standing at 0.0. The debt to equity ratio resting at 8.02. The interest coverage ratio of the stock is -11.36.
Currently, EBITDA for the company is -91.48 million with net debt to EBITDA at -2.17. When we switch over and look at the enterprise to sales, we see a ratio of 1.13. The receivables turnover for the company is 7.21for trailing twelve months and the total asset turnover is 0.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.49.
Conclusion
In summary, Beauty Health Company (SKIN) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
